CL2013003501A1 - Composición veterinaria para combatir parásitos en animales, que comprende una lactona macrocíclica (ej. doramectina), sal de levamisol y surfactante al menos 15% p/v; uso de dicha composición - Google Patents
Composición veterinaria para combatir parásitos en animales, que comprende una lactona macrocíclica (ej. doramectina), sal de levamisol y surfactante al menos 15% p/v; uso de dicha composiciónInfo
- Publication number
- CL2013003501A1 CL2013003501A1 CL2013003501A CL2013003501A CL2013003501A1 CL 2013003501 A1 CL2013003501 A1 CL 2013003501A1 CL 2013003501 A CL2013003501 A CL 2013003501A CL 2013003501 A CL2013003501 A CL 2013003501A CL 2013003501 A1 CL2013003501 A1 CL 2013003501A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- doramectin
- surfactant
- animals
- macrocyclic lactone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
- A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Esta solicitud de invención está relacionada a una composición veterinaria para combatir parásitos en animales. La composición comprende una lactona macrocíclica (ejemplificado con doramectina), una sal de levamisol y un surfactante (agente tensoactivo) a lo menos en 15% p/v, que permite solubilizar la doramectina y mantener bioactivos ambos antiparasitarios en la composición entre valores de pH de 2 a 4. Otros componentes de la composición son un estabilizador, un antioxidante, un agente quelante y un conservante. La bioactividad de la composición está ejemplificada al inyectar la composición en vacas para eliminar huevos de los parásitos Trichostrongylus sp. y Cooperia sp., en la materia fecal de animales faenados y no faenados, y se compara con el uso del antiparasitario comercial Dectomax. La composición de la presente invención posee mayor eficacia en la eliminación de huevos de dichos parásitos en comparación con el antiparasitario comercial.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ59371311 | 2011-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013003501A1 true CL2013003501A1 (es) | 2014-06-27 |
Family
ID=47422791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013003501A CL2013003501A1 (es) | 2011-06-23 | 2013-12-05 | Composición veterinaria para combatir parásitos en animales, que comprende una lactona macrocíclica (ej. doramectina), sal de levamisol y surfactante al menos 15% p/v; uso de dicha composición |
Country Status (19)
Country | Link |
---|---|
US (1) | US9198430B2 (es) |
EP (1) | EP2723335A4 (es) |
JP (1) | JP6120834B2 (es) |
KR (1) | KR20140047617A (es) |
CN (1) | CN103717218B (es) |
AU (1) | AU2012273538B2 (es) |
BR (1) | BR112013032567B1 (es) |
CA (1) | CA2839491A1 (es) |
CL (1) | CL2013003501A1 (es) |
CO (1) | CO6842017A2 (es) |
CR (1) | CR20130642A (es) |
DO (1) | DOP2013000289A (es) |
IL (1) | IL230074A (es) |
MX (1) | MX355769B (es) |
NI (1) | NI201300139A (es) |
PE (1) | PE20141179A1 (es) |
RU (1) | RU2591082C2 (es) |
UA (1) | UA113179C2 (es) |
WO (1) | WO2012177151A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2874624B8 (en) * | 2012-07-17 | 2019-10-02 | Bayer New Zealand Limited | Injectable antibiotic formulations and their methods of use |
JP6499970B2 (ja) * | 2013-10-30 | 2019-04-10 | 大蔵製薬株式会社 | 服用し易いゼリー状医薬組成物 |
WO2019101971A1 (en) * | 2017-11-23 | 2019-05-31 | Ceva Sante Animale | Composition for treating parasites infestations |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773422A (en) * | 1996-01-29 | 1998-06-30 | Komer; Gene | Avermectin formulation |
NZ508969A (en) | 1999-06-04 | 2002-12-20 | Nufarm Ltd | Pesticidal emulsion containing levamisole in the aqueous phase and a macrocyclic lactone anthelmintic in the organic phase |
WO2000074489A1 (en) | 1999-06-04 | 2000-12-14 | Nufarm Limited | Stable biocidal compositions |
CN1375293A (zh) | 2001-03-16 | 2002-10-23 | 王玉万 | 含碘醚柳胺的复方注射用驱虫药 |
NZ520295A (en) * | 2002-07-19 | 2005-04-29 | Ashmont Holdings Ltd | Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin |
AU2003900505A0 (en) | 2003-02-05 | 2003-02-20 | Jurox Pty Ltd | Anthelmintic composition |
US7645459B2 (en) * | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
BRPI0506279B1 (pt) | 2005-12-16 | 2018-01-09 | Npa - Núcleo De Pesquisas Aplicadas Ltda | Composição sinergística de antihelmínticos e endectocidas |
NZ552040A (en) * | 2006-12-13 | 2009-04-30 | Bomac Research Ltd | Veterinary formulation comprising an anthelmintic compound and glyceryl acetate |
NZ552293A (en) | 2006-12-21 | 2009-03-31 | Bomac Research Ltd | Tablet formulation comprising a macrocyclic lactone and a levamisole compound having anthelmintic activity |
EP2362774A1 (en) | 2008-08-18 | 2011-09-07 | Intervet International BV | Anthelmintic compositions |
AU2010100349B4 (en) | 2009-04-15 | 2012-03-29 | Jurox Pty Ltd | Anthelmintic formulation |
NZ570591A (en) | 2009-08-18 | 2012-01-12 | Intervet Int Bv | Anthelmintic compositions |
EP2568980B1 (en) | 2010-05-12 | 2015-11-11 | Merial, Inc. | Injectable parasiticidal formulations of levamisole and macrocyclic lactones |
-
2012
- 2012-06-22 UA UAA201400624A patent/UA113179C2/uk unknown
- 2012-06-22 KR KR1020137033836A patent/KR20140047617A/ko active Search and Examination
- 2012-06-22 RU RU2014101995/15A patent/RU2591082C2/ru active
- 2012-06-22 US US14/129,101 patent/US9198430B2/en not_active Expired - Fee Related
- 2012-06-22 PE PE2013002835A patent/PE20141179A1/es not_active Application Discontinuation
- 2012-06-22 MX MX2013014460A patent/MX355769B/es active IP Right Grant
- 2012-06-22 WO PCT/NZ2012/000104 patent/WO2012177151A1/en active Application Filing
- 2012-06-22 BR BR112013032567A patent/BR112013032567B1/pt active IP Right Grant
- 2012-06-22 EP EP12802571.5A patent/EP2723335A4/en not_active Withdrawn
- 2012-06-22 AU AU2012273538A patent/AU2012273538B2/en active Active
- 2012-06-22 CA CA2839491A patent/CA2839491A1/en not_active Abandoned
- 2012-06-22 CN CN201280031106.7A patent/CN103717218B/zh active Active
- 2012-06-22 JP JP2014516944A patent/JP6120834B2/ja active Active
-
2013
- 2013-12-05 CL CL2013003501A patent/CL2013003501A1/es unknown
- 2013-12-06 DO DO2013000289A patent/DOP2013000289A/es unknown
- 2013-12-09 CR CR20130642A patent/CR20130642A/es unknown
- 2013-12-11 NI NI201300139A patent/NI201300139A/es unknown
- 2013-12-20 CO CO13298004A patent/CO6842017A2/es not_active Application Discontinuation
- 2013-12-22 IL IL230074A patent/IL230074A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP2723335A4 (en) | 2015-01-07 |
CA2839491A1 (en) | 2012-12-27 |
CN103717218A (zh) | 2014-04-09 |
CR20130642A (es) | 2014-02-19 |
RU2014101995A (ru) | 2015-07-27 |
MX355769B (es) | 2018-04-30 |
MX2013014460A (es) | 2014-04-14 |
US9198430B2 (en) | 2015-12-01 |
AU2012273538A1 (en) | 2013-05-02 |
JP2014517066A (ja) | 2014-07-17 |
US20140221299A1 (en) | 2014-08-07 |
BR112013032567B1 (pt) | 2020-04-28 |
DOP2013000289A (es) | 2014-03-16 |
CN103717218B (zh) | 2017-09-12 |
KR20140047617A (ko) | 2014-04-22 |
WO2012177151A1 (en) | 2012-12-27 |
PE20141179A1 (es) | 2014-10-11 |
JP6120834B2 (ja) | 2017-04-26 |
UA113179C2 (xx) | 2016-12-26 |
EP2723335A1 (en) | 2014-04-30 |
RU2591082C2 (ru) | 2016-07-10 |
BR112013032567A2 (pt) | 2017-01-24 |
NI201300139A (es) | 2014-02-26 |
CO6842017A2 (es) | 2014-01-20 |
IL230074A (en) | 2016-10-31 |
AU2012273538B2 (en) | 2015-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2020000739A1 (es) | Agente prolongado de control de ectoparasito para animales. | |
CL2017002936A1 (es) | Compuestos ciclooctadepsipéptidos, composición veterinaria antihelmíntica, y uso para preparar un medicamento útil contra infección por parásitos o una infestación por parásitos internos o externos en un animal. | |
CL2014003509A1 (es) | Composición veterinaria masticable blanda que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal (div. sol. n°2087-14). | |
CL2018001744A1 (es) | Compuestos depsipeptídicos como anthelmínticos | |
CL2012002770A1 (es) | Compuestos derivados de 3,5-difenil-5-trifluoro-isoxazolina sustituidos; composición veterinaria; y su uso como ectoparasiticidas para tratar una infección e infestación por ácaros e insectos en animales y pájaros. | |
CL2017002164A1 (es) | Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas | |
CL2014000601A1 (es) | Composición tópica veterinaria que comprende al menos un agente activo derivado de isoxazolina; y uso de la composición para el tratamiento o prevención de una infestación o infección por parásitos en un animal. | |
CO2018008829A2 (es) | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos | |
CO2017010065A2 (es) | Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina | |
GT201000160A (es) | Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales | |
CL2018000525A1 (es) | Derivados de espinosina y métodos de preparación. | |
CL2013003501A1 (es) | Composición veterinaria para combatir parásitos en animales, que comprende una lactona macrocíclica (ej. doramectina), sal de levamisol y surfactante al menos 15% p/v; uso de dicha composición | |
BR112015020089A2 (pt) | Formulação aquosa de tratamento de semente, formulação pesticida aquosa, e, método para preparar uma formulação | |
AR043824A1 (es) | Composiciones y metodo para tratar las infecciones microbianas y parasitarias en el ganado y otros animales | |
MX2019009369A (es) | Modelo in vivo para infeccion de gusano parasitico y metodos para evaluar compuestos antiparasiticos, que incluyen compuestos activos contra gusano del corazon canino. | |
CR20150508A (es) | Formulaciones veterinarias estables de combinación de lactonas macrocíclicas e imidazotiazoles | |
AR099584A1 (es) | Combinaciones de compuestos activos que tienen propiedades insecticidas | |
NZ717434A (en) | A veterinary method for inducing emesis | |
AR094749A1 (es) | Composiciones que comprenden un agente de control biológico y un insecticida | |
CO6640293A2 (es) | Composiciones y métodos para el control de jejenes y otors insectos hematófagos | |
AR126245A2 (es) | Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos | |
CL2018001681A1 (es) | Formulación con acción repelente a insectos para protección de superficies | |
CL2008002899A1 (es) | Composicion farmaceutica veterinaria que comprende 4"-deoxi-4"epimetilamino avermectina b1a/b1b como ingrediente activo; procedimiento para preparar dicha composicion; uso de la composicion para tratar o prevenir enfermedades parasitarias en salmones y truchas. |